Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 07:49:06 28/05/2024 pm IST 		5-day change 1st Jan Change
0.942 EUR -0.84% Intraday chart for Lavipharm S.A. -3.88% +18.34%
28/02 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. News Lavipharm S.A.
  5. Analyst Reco.